Idioma:

Evaluation of the efficacy and safety of intravenous infusion of ferric derisomaltose in the treatment of iron deficiency anemia: a single-center retrospective analysis

Ding, S X ; Zhao, Y H ; Wang, T ; Guan, J ; Xing, L M ; Liu, H ; Wang, G J ; Wang, X M ; Wu, Y H ; Qu, W ; Song, J ; Wang, H Q ; Li, L J ; Shao, Z H ; Fu, R

Zhōnghuá xuèyèxué zázhì, 2024-02, Vol.45 (2), p.178-183

China

Texto completo disponível

Citações Citado por

Enviar para

Título:
Evaluation of the efficacy and safety of intravenous infusion of ferric derisomaltose in the treatment of iron deficiency anemia: a single-center retrospective analysis
Autor: Ding, S X ; Zhao, Y H ; Wang, T ; Guan, J ; Xing, L M ; Liu, H ; Wang, G J ; Wang, X M ; Wu, Y H ; Qu, W ; Song, J ; Wang, H Q ; Li, L J ; Shao, Z H ; Fu, R
Assuntos: Anemia, Iron-Deficiency - chemically induced ; Anemia, Iron-Deficiency - drug therapy ; Disaccharides ; Ferric Compounds - adverse effects ; Ferric Compounds - therapeutic use ; Ferric Oxide, Saccharated - therapeutic use ; Hemoglobins - analysis ; Hemoglobins - therapeutic use ; Humans ; Infusions, Intravenous ; Iron ; Retrospective Studies
É parte de: Zhōnghuá xuèyèxué zázhì, 2024-02, Vol.45 (2), p.178-183
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: To investigate the clinical efficacy and safety of ferric derisomaltose injection versus iron sucrose injection in the treatment of iron deficiency anemia (IDA) . A total of 120 patients with iron deficiency anemia admitted from June 2021 to March 2023 were given intravenous iron supplementation with ferric derisomaltose to assess the efficacy and safety of hemoglobin (HGB) elevation before and after treatment. Simultaneously, the clinical effects of iron supplementation with iron sucrose were compared to those of inpatient patients during the same period. Baseline values were comparable in both groups. Within 12 weeks of treatment, the elevated HGB level in the ferric derisomaltose group was higher than that of the iron sucrose group, with a statistical difference at all time points, and the proportion of HGB increased over 20 g/L in the patients treated for 4 weeks was higher (98.7%, 75.9% ). During the treatment with ferric derisomaltose and iron sucrose, the proportion of mild adverse reactions in the fer
Editor: China
Idioma: Chinês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 14 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Evaluation of the efficacy and safety of intravenous infusion of ferric derisomaltose in the treatment of iron deficiency anemia: a single-center retrospective analysis

Ding, S X ; Zhao, Y H ; Wang, T ; Guan, J ; Xing, L M ; Liu, H ; Wang, G J ; Wang, X M ; Wu, Y H ; Qu, W ; Song, J ; Wang, H Q ; Li, L J ; Shao, Z H ; Fu, R

China

Buscando em bases de dados remotas. Favor aguardar.